(25)
17 Giugno 2013 - 2:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING
AND/OR REGISTRATION UNDER SECTION 12(b)
OF THE SECURITIES EXCHANGE ACT
OF 1934.
Commission File Number:
001-35182
Issuer: Ampio Pharmaceuticals, Inc.
Exchange: NASDAQ Stock Market LLC
(Exact name of Issuer as specified in
its charter, and name of Exchange
where security is listed and/or registered)
5445 DTC Parkway, Suite 925, Greenwood Village, Colorado 80111
(720) 437-6500
(Address, including zip code, and telephone number, including area code, of Issuers principal executive offices)
Common Stock, par value $0.0001 per share
(Description of class of
securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
¨
|
17 CFR 240.12d2-2(a)(1)
|
¨
|
17 CFR 240.12d2-2(a)(2)
|
¨
|
17 CFR 240.12d2-2(a)(3)
|
¨
|
17 CFR 240.12d2-2(a)(4)
|
¨
|
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the
Exchange.
|
x
|
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the
voluntary withdrawal of the class of securities from listing and registration on the Exchange.
|
Pursuant to the requirements of
the Securities Exchange Act of 1934, Ampio Pharmaceuticals, Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the
undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
June 17, 2013
|
|
|
|
By:
|
|
/s/ Mark D. McGregor
|
|
|
|
Chief Financial Officer
|
|
|
|
|
|
|
Mark D. McGregor
|
|
|
|
|